Search

Prince Akwasi Mensah

Examiner (ID: 16550, Phone: (571)270-7183 , Office: P/2474 )

Most Active Art Unit
2474
Art Unit(s)
2416, 2474
Total Applications
590
Issued Applications
431
Pending Applications
63
Abandoned Applications
119

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7122847 [patent_doc_number] => 20050014676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Methods for delaying or inducing labor' [patent_app_type] => utility [patent_app_number] => 10/620317 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5960 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014676.pdf [firstpage_image] =>[orig_patent_app_number] => 10620317 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/620317
Methods for delaying or inducing labor Jul 14, 2003 Abandoned
Array ( [id] => 7136300 [patent_doc_number] => 20040044008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Use of therapeutic benzamide derivatives' [patent_app_type] => new [patent_app_number] => 10/296794 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21849 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044008.pdf [firstpage_image] =>[orig_patent_app_number] => 10296794 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/296794
Use of therapeutic benzamide derivatives Jul 10, 2003 Abandoned
Array ( [id] => 7449760 [patent_doc_number] => 20040009994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions' [patent_app_type] => new [patent_app_number] => 10/615282 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17884 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009994.pdf [firstpage_image] =>[orig_patent_app_number] => 10615282 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/615282
Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions Jul 6, 2003 Abandoned
Array ( [id] => 7355685 [patent_doc_number] => 20040048887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/614382 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12166 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048887.pdf [firstpage_image] =>[orig_patent_app_number] => 10614382 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/614382
Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors Jul 6, 2003 Abandoned
Array ( [id] => 7136333 [patent_doc_number] => 20040044020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => ' Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/611717 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 51218 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044020.pdf [firstpage_image] =>[orig_patent_app_number] => 10611717 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/611717
Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors Jun 30, 2003 Abandoned
Array ( [id] => 5709969 [patent_doc_number] => 20060051314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Drug for prevention and/or treatment of constipation and sympton caused by constipation' [patent_app_type] => utility [patent_app_number] => 10/514722 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9257 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051314.pdf [firstpage_image] =>[orig_patent_app_number] => 10514722 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514722
Drug for prevention and/or treatment of constipation and sympton caused by constipation Jun 25, 2003 Abandoned
Array ( [id] => 7468063 [patent_doc_number] => 20040053906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Method and composition of novel compounds for the therapy and targeting of the primary modalitites of cancer cell proliferation and homeostasis' [patent_app_type] => new [patent_app_number] => 10/603571 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2836 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053906.pdf [firstpage_image] =>[orig_patent_app_number] => 10603571 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/603571
Method and composition of novel compounds for the therapy and targeting of the primary modalitites of cancer cell proliferation and homeostasis Jun 24, 2003 Abandoned
Array ( [id] => 7437355 [patent_doc_number] => 20040002534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds' [patent_app_type] => new [patent_app_number] => 10/600868 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15890 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002534.pdf [firstpage_image] =>[orig_patent_app_number] => 10600868 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/600868
Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds Jun 22, 2003 Abandoned
Array ( [id] => 5913698 [patent_doc_number] => 20060128760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Use of mglur5 antagonists for the treatment of gerd' [patent_app_type] => utility [patent_app_number] => 10/517869 [patent_app_country] => US [patent_app_date] => 2003-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2945 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128760.pdf [firstpage_image] =>[orig_patent_app_number] => 10517869 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/517869
Use of mGluR5 antagonists for the treatment of gerd Jun 18, 2003 Issued
Array ( [id] => 7314654 [patent_doc_number] => 20040034075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Sphingosine kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/462954 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13053 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034075.pdf [firstpage_image] =>[orig_patent_app_number] => 10462954 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/462954
Sphingosine kinase inhibitors Jun 16, 2003 Issued
Array ( [id] => 733136 [patent_doc_number] => 07037934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Blood lipid ameliorant composition' [patent_app_type] => utility [patent_app_number] => 10/460535 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3318 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037934.pdf [firstpage_image] =>[orig_patent_app_number] => 10460535 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/460535
Blood lipid ameliorant composition Jun 10, 2003 Issued
Array ( [id] => 8538356 [patent_doc_number] => 08314077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Fatty acid-pharmaceutical agent conjugates' [patent_app_type] => utility [patent_app_number] => 10/455250 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 16210 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10455250 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/455250
Fatty acid-pharmaceutical agent conjugates Jun 4, 2003 Issued
Array ( [id] => 5632300 [patent_doc_number] => 20060148770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Combinations for the treatment of rheumatoid arithritis' [patent_app_type] => utility [patent_app_number] => 10/517639 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5055 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148770.pdf [firstpage_image] =>[orig_patent_app_number] => 10517639 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/517639
Combinations for the treatment of rheumatoid arithritis Jun 4, 2003 Abandoned
10/088678 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway Jun 3, 2003 Abandoned
Array ( [id] => 7136251 [patent_doc_number] => 20040043992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Meloxicam for alleviating organ injury during organ operation or transplantation' [patent_app_type] => new [patent_app_number] => 10/443156 [patent_app_country] => US [patent_app_date] => 2003-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2380 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043992.pdf [firstpage_image] =>[orig_patent_app_number] => 10443156 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/443156
Meloxicam for alleviating organ injury during organ operation or transplantation May 20, 2003 Abandoned
Array ( [id] => 5591493 [patent_doc_number] => 20060040945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Annellated pyrrole compounds as proton pump inhibitors for treating ulcer' [patent_app_type] => utility [patent_app_number] => 10/513327 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10342 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040945.pdf [firstpage_image] =>[orig_patent_app_number] => 10513327 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/513327
Annellated pyrrole compounds as proton pump inhibitors for treating ulcer May 15, 2003 Abandoned
Array ( [id] => 7138209 [patent_doc_number] => 20050182042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic' [patent_app_type] => utility [patent_app_number] => 10/514683 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5660 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182042.pdf [firstpage_image] =>[orig_patent_app_number] => 10514683 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514683
Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic May 15, 2003 Abandoned
Array ( [id] => 7314699 [patent_doc_number] => 20040034087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Synergistic combination' [patent_app_type] => new [patent_app_number] => 10/437005 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2658 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034087.pdf [firstpage_image] =>[orig_patent_app_number] => 10437005 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/437005
Synergistic combination May 13, 2003 Issued
10/344241 Oral delivery of peptide May 11, 2003 Abandoned
Array ( [id] => 7089753 [patent_doc_number] => 20050009866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Treatment of cardiovascular disease with quinolinone enantiomers' [patent_app_type] => utility [patent_app_number] => 10/435999 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10135 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009866.pdf [firstpage_image] =>[orig_patent_app_number] => 10435999 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/435999
Treatment of cardiovascular disease with quinolinone enantiomers May 11, 2003 Abandoned
Menu